{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:44:01Z","timestamp":1777419841768,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Transcutaneous bilirubinometry is a widely used screening method for neonatal hyperbilirubinemia. Deviation of the transcutaneous bilirubin concentration (TcB) from the total serum bilirubin concentration (TSB) is often ascribed to biological variation between patients, but variations between TcB meters may also have a role. This study aims to provide a systematic evaluation of the inter-device reproducibility of TcB meters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and Methods<\/jats:title>\n                <jats:p>Thirteen commercially available TcB meters (JM-105 and JM-103) were evaluated in vitro on phantoms that optically mimic neonatal skin. The mimicked TcB was varied within the clinical range (0.5\u2013181.3 \u03bcmol\/L).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Absolute differences between TcB meter outcomes increased with the measured TcB, from a difference of 5.0 \u03bcmol\/L (TcB\u2009=\u20090.5 \u03bcmol\/L phantom) up to 65.0 \u03bcmol\/L (TcB\u2009=\u2009181.3 \u03bcmol\/L phantom).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The inter-device reproducibility of the examined TcB meters is substantial and exceeds the specified accuracy of the device (\u00b125.5 \u03bcmol\/L), as well as the clinically used TcB safety margins (&gt;50 \u00b5mol\/L below phototherapy threshold). Healthcare providers should be well aware of this additional uncertainty in the TcB determination, especially when multiple TcB meters are employed in the same clinic. We strongly advise using a single TcB meter per patient to evaluate the TcB over time.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Impact<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>Key message: The inter-device reproducibility of TcB meters is substantial and exceeds the clinically used TcB safety margins.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>What this study adds to existing literature: The inter-device reproducibility of transcutaneous bilirubin (TcB) meters has not been reported in the existing literature. This in vitro study systematically evaluates this inter-device reproducibility.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Impact: This study aids in a better interpretation of the measured TcB value from a patient and is of particular importance during patient monitoring when using multiple TcB meters within the same clinical department. We strongly advise using a single TcB meter per patient to evaluate the TcB over time.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41390-020-01118-6","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T12:02:59Z","timestamp":1599912179000},"page":"770-775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Inter-device reproducibility of transcutaneous bilirubin meters"],"prefix":"10.1038","volume":"89","author":[{"given":"Alida J.","family":"Dam-Vervloet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlijn D.","family":"van Erk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Doorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan G. J.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nienke A.","family":"Timmermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen","family":"Vanwinsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foky-Anna","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrica L. M.","family":"van Straaten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nienke","family":"Bosschaart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"1118_CR1","first-page":"199","volume":"13","author":"JB Le Pichon","year":"2017","unstructured":"Le Pichon, J. B., Riordan, S. M., Watchko, J. & Shapiro, S. M. The neurological sequelae of neonatal hyperbilirubinemia: definitions, diagnosis and treatment of the kernicterus spectrum disorders (KSDs). Curr. Pediatr. Rev. 13, 199\u2013209 (2017).","journal-title":"Curr. Pediatr. Rev."},{"key":"1118_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1542\/peds.114.1.297","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia.","year":"2004","unstructured":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114, 297\u2013316 (2004).","journal-title":"Pediatrics"},{"key":"1118_CR3","unstructured":"National Institute for Health and Clinical Excellence (NICE). Neonatal jaundice clinical guideline. https:\/\/www.nice.org.uk\/guidance\/cg98\/resources\/jaundice-in-newborn-babies-under-28-days-975756073669. Accessed Aug 2019 (2010)"},{"key":"1118_CR4","doi-asserted-by":"publisher","first-page":"e20162414","DOI":"10.1542\/peds.2016-2414","volume":"138","author":"B van den Esker-Jonker","year":"2016","unstructured":"van den Esker-Jonker, B., den Boer, L., Pepping, R. M. C. & Bekhof, J. Transcutaneous bilirubinometry in jaundiced neonates: a randomized controlled trial. Pediatrics 138, e20162414 (2016).","journal-title":"Pediatrics"},{"key":"1118_CR5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1542\/peds.2011-2586","volume":"129","author":"N Bosschaart","year":"2012","unstructured":"Bosschaart, N. et al. Limitations and opportunities of transcutaneous bilirubin measurements. Pediatrics 129, 689\u2013694 (2012).","journal-title":"Pediatrics"},{"key":"1118_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1542\/peds.65.2.195","volume":"65","author":"I Yamanouchi","year":"1980","unstructured":"Yamanouchi, I., Yamauchi, Y. & Igarashi, I. Transcutaneous bilirubinometry: preliminary studies of noninvasive transcutaneous bilirubin meter in the Okayama National Hospital. Pediatrics 65, 195\u2013202 (1980).","journal-title":"Pediatrics"},{"key":"1118_CR7","unstructured":"Dr\u00e4ger Medical System, Inc. Manual JM-105. Telford, USA, (2016)."},{"key":"1118_CR8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1542\/peds.2013-1713","volume":"132","author":"G Nagar","year":"2013","unstructured":"Nagar, G., Vandermeer, B., Campbell, S. & Kumar, M. Reliability of transcutaneous bilirubin devices in term and near-term infants: a systematic review and meta-analysis. Pediatrics 132, 871\u2013881 (2013).","journal-title":"Pediatrics"},{"key":"1118_CR9","unstructured":"Nederlandse vereniging voor Kindergeneeskunde (NVK). Richtlijn preventie, diagnostiek en behandeling van hyperbilirubinemie bij de pasgeborene, geboren na een zwangerschapsduur van meer dan 35 weken. https:\/\/werkboeken.nvk.nl\/Portals\/0\/richtlijnen\/hyperbili\/richtlijnhyperbili.pdf. Accessed June 2020 (2008)."},{"key":"1118_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41390-019-0471-z","volume":"86","author":"MD van Erk","year":"2019","unstructured":"van Erk, M. D. et al. How skin anatomy influences transcutaneous bilirubin determinations: an in vitro evaluation. Pediatr. Res. 86, 471\u2013477 (2019).","journal-title":"Pediatr. Res."},{"key":"1118_CR11","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1542\/peds.113.6.1628","volume":"113","author":"MJ Maisels","year":"2004","unstructured":"Maisels, M. J. et al. Evaluation of a new transcutaneous bilirubinometer. Pediatrics 113, 1628\u20131635 (2004).","journal-title":"Pediatrics"},{"key":"1118_CR12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1542\/peds.2005-0590","volume":"117","author":"K Grohmann","year":"2006","unstructured":"Grohmann, K. et al. Bilirubin measurement for neonates: comparison of 9 frequently used methods. Pediatrics 117, 1174\u20131183 (2006).","journal-title":"Pediatrics"},{"key":"1118_CR13","doi-asserted-by":"publisher","first-page":"097003","DOI":"10.1117\/1.3622629","volume":"16","author":"N Bosschaart","year":"2011","unstructured":"Bosschaart, N., Mentink, R., Kok, J. H., van Leeuwen, T. G. & Aalders, M. C. Optical properties of neonatal skin measured in vivo as a function of age and skin pigmentation. J. Biomed. Opt. 16, 097003 (2011).","journal-title":"J. Biomed. Opt."},{"key":"1118_CR14","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.1364\/AO.34.007410","volume":"34","author":"IS Saidi","year":"1995","unstructured":"Saidi, I. S., Jacques, S. L. & Tittel, F. K. Mie and Rayleigh modeling of visible-light scattering in neonatal skin. Appl Opt. 34, 7410\u20137418 (1995).","journal-title":"Appl Opt."},{"key":"1118_CR15","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1364\/BOE.9.003581","volume":"9","author":"C Veenstra","year":"2018","unstructured":"Veenstra, C., Petersen, W., Vellekoop, I. M., Steenbergen, W. & Bosschaart, N. Spatially confined quantification of bilirubin concentrations by spectroscopic visible-light optical coherence tomography. Biomed. Opt. Express 9, 3581\u20133589 (2018).","journal-title":"Biomed. Opt. Express"},{"key":"1118_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000242513","volume":"49","author":"NJ Evans","year":"1986","unstructured":"Evans, N. J. & Rutter, N. Development of the epidermis in the newborn. Neonatology 49, 74\u201380 (1986).","journal-title":"Neonatology"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01118-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01118-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01118-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T23:14:55Z","timestamp":1631402095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01118-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1038\/s41390-020-01118-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]},"assertion":[{"value":"18 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No patient consent was required, because for this in vitro study, we used phantoms that optically mimic neonatal skin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}